Alnylam Pharmaceuticals | ALNY - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Incyte USD 3.98B 33.45M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 6.88B 2.68B 2026-03
PTC Therapeutics USD 1.05B 215.9M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 5.54B 2.11B 2026-03
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06
Xencor USD 44.66M 30.49M 2026-06